Profile | GDS4284 / 221681_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 345.523 | 59 |
GSM687648 | Patient 402 control | 174.538 | 46 |
GSM687653 | Patient 403 control | 215.069 | 51 |
GSM687658 | Patient 404 control | 292.872 | 55 |
GSM687663 | Patient 411 control | 376.552 | 59 |
GSM687668 | Patient 422 control | 179.103 | 47 |
GSM687673 | Patient 424 control | 231.407 | 50 |
GSM687678 | Patient 425 control | 283.643 | 54 |
GSM687683 | Patient 427 control | 355.523 | 57 |
GSM687688 | Patient 428 control | 302.851 | 56 |
GSM687695 | Patient 441 control | 662.824 | 67 |
GSM687699 | Patient 443 control | 285.082 | 52 |
GSM687704 | Patient 444 control | 331.369 | 57 |
GSM687707 | Patient 448 control | 362.148 | 57 |
GSM687712 | Patient 449 control | 234.228 | 51 |
GSM687719 | Patient 450 control | 303.584 | 53 |
GSM687724 | Patient 451 control | 284.83 | 54 |
GSM687728 | Patient 452 control | 196.825 | 47 |
GSM687646 | Patient 401 treated 24h | 316.708 | 56 |
GSM687649 | Patient 402 treated 24h | 137.023 | 43 |
GSM687665 | Patient 411 treated 24h | 312.223 | 55 |
GSM687651 | Patient 402 treated 4 weeks | 237.873 | 50 |
GSM687667 | Patient 411 treated 4 weeks | 221.646 | 50 |
GSM687670 | Patient 422 treated 24h | 247.424 | 51 |
GSM687671 | Patient 422 treated 4 weeks | 205.333 | 49 |
GSM687654 | Patient 403 treated 24h | 289.742 | 56 |
GSM687675 | Patient 424 treated 24h | 228.807 | 49 |
GSM687685 | Patient 427 treated 24h | 258.666 | 53 |
GSM687656 | Patient 403 treated 4 weeks | 154.852 | 46 |
GSM687677 | Patient 424 treated 4 weeks | 191.345 | 48 |
GSM687687 | Patient 427 treated 4 weeks | 115.594 | 39 |
GSM687692 | Patient 428 treated 4h | 238.902 | 51 |
GSM687716 | Patient 449 treated 4h | 175.003 | 46 |
GSM687722 | Patient 450 treated 4h | 367.594 | 57 |
GSM687680 | Patient 425 treated 24h | 235.439 | 51 |
GSM687690 | Patient 428 treated 24h | 180.841 | 47 |
GSM687700 | Patient 443 treated 24h | 493.966 | 60 |
GSM687705 | Patient 444 treated 24h | 269.496 | 55 |
GSM687714 | Patient 449 treated 24h | 182.402 | 48 |
GSM687721 | Patient 450 treated 24h | 244.968 | 48 |
GSM687682 | Patient 425 treated 4 weeks | 116.532 | 38 |
GSM687694 | Patient 428 treated 4 weeks | 227.976 | 52 |
GSM687702 | Patient 443 treated 4 weeks | 478.562 | 62 |
GSM687718 | Patient 449 treated 4 weeks | 324.812 | 57 |
GSM687723 | Patient 450 treated 4 weeks | 334.419 | 57 |
GSM687661 | Patient 404 treated 4h | 293.494 | 54 |
GSM687710 | Patient 448 treated 4h | 173.282 | 46 |
GSM687726 | Patient 451 treated 4h | 217.516 | 47 |
GSM687730 | Patient 452 treated 4h | 491.221 | 55 |
GSM687660 | Patient 404 treated 24h | 208.685 | 45 |
GSM687697 | Patient 441 treated 24h | 409.043 | 58 |
GSM687709 | Patient 448 treated 24h | 331.701 | 57 |
GSM687725 | Patient 451 treated 24h | 313.127 | 54 |
GSM687729 | Patient 452 treated 24h | 186.407 | 40 |
GSM687727 | Patient 451 treated 4 weeks | 278.699 | 52 |
GSM687731 | Patient 452 treated 4 weeks | 183.94 | 44 |